AlphaCentric Advisors’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
AlphaCentric Advisors's SNY Position: Q3 2026 in Review
AlphaCentric Advisors increased its Sanofi (SNY) stake by 5.2% in Q3 2026, buying an estimated $32.8K and bringing the position to 15,345 shares worth $633K. The position accounts for 0.56% of the portfolio, ranked #53.
AlphaCentric Advisors first reported a position in SNY in Q4 2021 and has held it in 11 quarters since. The position peaked at $2.11M in Q3 2022. 687 funds tracked by Wall St. Rank hold SNY as of Q3 2026.
- AlphaCentric Advisors held 15,345 shares of Sanofi worth $633K as of Q3 2026.
- AlphaCentric Advisors bought 755 Sanofi shares in Q3 2026, an estimated $32.8K.
- Sanofi made up 0.56% of AlphaCentric Advisors's portfolio in Q3 2026, its #53 holding.
- AlphaCentric Advisors first reported a position in Sanofi in Q4 2021 and has held it in 11 quarters since.
- AlphaCentric Advisors's Sanofi position peaked at $2.11M in Q3 2022.
- 687 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.
Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.